Real-Time Ablation Guidance Software
Solid Tumors (e.g., Lung Cancer)
Clinical TrialActive
Key Facts
About NE Scientific
NE Scientific is a pioneer in real-time simulation software for percutaneous ablation, a minimally invasive cancer treatment. The company addresses a critical clinical gap where 10-30% of procedures leave untreated tumor tissue due to a lack of intraoperative guidance, leading to recurrence. Its core technology uses GPU acceleration to model ablation physics (RFA, MWA, Cryo, etc.) in real-time, overlaying the predicted treatment zone on live imaging to guide physicians. Backed by over $1.8M in NCI SBIR grants and industry awards from Johnson & Johnson and NVIDIA, NE Scientific has progressed its technology into clinical trials.
View full company profileTherapeutic Areas
Other Solid Tumors (e.g., Lung Cancer) Drugs
| Drug | Company | Phase |
|---|---|---|
| ARAC-02 (ARAC™) | Pdx Pharmaceuticals | Preclinical |